Skip to content. | Skip to navigation

Personal tools
Log in
You are here: Home Know-who Know-how Directory By type of organisation Diversified life sciences company

Diversified life sciences company

Diversified life sciences companies are companies that are actively involved in R&D, production and/or marketing of life sciences products, but their core business is not (solely) in life sciences.

Avantium Technologies B.V.

Business focus: Product development, Services and Equipment in Energy, Chemical and Pharma sectors aimed at catalysis and crystallization research using high-throughput technology.

Read More…

Clinquest Group

Business focus: Product Development Organisation (PDO), we develop and implement comprehensive product development programs to bring products from early preclinical stage to market approval.

Read More…

DUCARES B.V.

Business focus: DUCARES aims to significantly contribute to the enhancement of medical care on an international level with knowledge and expertise in the field of applied and advanced analytical research.

Read More…

Farmalyse B.V.

Business focus: GMP Contract Services; Contract Research; cannabinoid formulation; cannabinoid reference standards.

Read More…

FeyeCon Carbon Dioxide Technologies

FeyeCon specializes in applying Supercritical Fluid Technology for solutions in formulation issues, particle design or solvent removal

Read More…

Genzyme Nederland

Business focus: Genzyme’s products and services are focused on rare inherited disorders, kidney disease, orthopaedics, transplant, cancer, and diagnostic testing. Genzyme’s commitment to innovation continues today with a substantial research and development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

Read More…

Holland Health

Business focus: To become a center of excellence in North-Holland North in the field off medical innovation in health care.

Read More…

KAIN

Contract research and consultancy with a focus on analytical chemistry.

Read More…

Medical Brands BV

Business focus: Development, outsourced manufacturing, sales and distribution of medical products between cosmetic and pharmaceutical registration with health claims. We focus on creating the next medical brands.

Read More…

Nycomed bv

Business focus: Pain, respiratory, cardiology, gastroenterology, tissue management, osteoporose. New products are sourced both from our own research and from business partners at various stages in development.

Read More…

Personal Space Technologies

Business focus: Solutions for the intuitive rapid analysis of complex 3D and 4D medical images.

Read More…

Progressare BV

Business focus: Development, outsourced manufacturing, licenses of medical products between cosmetics and pharmaceutical categories. Products are registered as medical devices or combination products (medical device and pharmaceutical mode of action). Most products are OTC (over-the-counter) sold.

Read More…

Progressare Medinvest BV

Business focus: Development, outsourced manufacturing, sales and distribution of medical products between cosmetic and pharmaceutical registration with health claims. We focus on Private Labeling.

Read More…

Sigmascreening

Sigmascreening develops and delivers alternative approaches to breast cancer screening.

Read More…

XenoBiosis International B.V.

Business focus: A company that develops and manufactures biologically active compounds of plant origin for the pharmaceutical, functional foods and cosmetic industry.

Read More…

Document Actions

Find your life sciences partner in the Amsterdam BioMed Cluster

Find your life sciences partner in the Amsterdam BioMed Cluster

Column

Penny-wise!

Synaps bij column Arjen Brussaard, foto CNCR.nl

By Arjen Brussaard

Recently the topsector plan Life Sciences & Health was published and presented to Minister Verhagen, of the so-called ELI Ministry. The document is an amazing compressed 60-pager, based on months of hard work by the group of experts chaired by Roel Fonville, and summarizes the conclusions after dozens of 1-to-1 meetings, five regional group sessions with dozens of opinion leaders and after having received over 170 (!) memo's, white papers and letters of intent.
More...